Catalyst Wire Dossier Catalyst Wire Dossier

PF614

· Ensysce Biosciences
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for PF614, covering 2024-09-24 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102) [Phase 1]

See pricing